Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 9

    Early, rapid and reliable blood tests are the best way to fight dengue outbreak

    Early, rapid and reliable blood tests are the best way to fight dengue outbreak

    Ruby Khatun Khatun25 Sept 2017 9:47 AM IST
    Mumbai: Following the water deluge on August 29, Mumbaikars are now facing a deluge of Dengue cases. In the first fortnight of September itself, 1,659...
    Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

    Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

    Ruby Khatun Khatun25 Sept 2017 9:21 AM IST
    Basel: Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current...
    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Ruby Khatun Khatun19 Sept 2017 10:29 AM IST
    Mumbai: Pharma Major Lupin announced the appointment of Jim Loerop as Chief Corporate Development Officer. Jim will lead Lupin's overall corporate...
    FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

    FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

    Ruby Khatun Khatun19 Sept 2017 9:24 AM IST
    ATLANTA and BRUSSELS: UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...
    Mylan launches generic Minastrin® 24 FE tablets in US

    Mylan launches generic Minastrin® 24 FE tablets in US

    Ruby Khatun Khatun18 Sept 2017 10:38 AM IST
    HERTFORDSHIRE, England, and PITTSBURGH: Mylan N.V. announced the U.S. launch of Norethindrone Acetate and Ethinyl Estradiol Tablets USP, and Ferrous...
    UST Global invests in MyDoc, a Singapore-based digital health platform company

    UST Global invests in MyDoc, a Singapore-based digital health platform company

    Ruby Khatun Khatun15 Sept 2017 10:07 AM IST
    THIRUVANANTHAPURAM: UST Global has made a strategic investment in MyDoc, a Singapore-based digital health platform company, to expand its digital...
    Johnson and Johnson arm Janssen to discontinue Hepatitis C development program

    Johnson and Johnson arm Janssen to discontinue Hepatitis C development program

    Ruby Khatun Khatun14 Sept 2017 10:02 AM IST
    CORK, Ireland: Janssen Sciences Ireland UC (Janssen), announced a strategic decision to discontinue further development of the investigational...
    OrbiMed lines up 551 million dollar healthcare PE fund for China, India

    OrbiMed lines up 551 million dollar healthcare PE fund for China, India

    Ruby Khatun Khatun9 Sept 2017 10:17 AM IST
    NEW YORK: OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its third Asia-focused private equity fund,...
    Indias loss is over Rs 60 lakh crore each year due to poor healthcare: Vazirani

    Indias loss is over Rs 60 lakh crore each year due to poor healthcare: Vazirani

    Ruby Khatun Khatun8 Sept 2017 1:28 PM IST
    Mumbai: The 10th Medtech Conference of Confederation of Indian Industries (CII) witnessed the coming together of officials from the Central and State...
    Fitbit launches Ionic, the ultimate health and fitness smartwatch

    Fitbit launches Ionic, the ultimate health and fitness smartwatch

    Ruby Khatun Khatun3 Sept 2017 9:49 AM IST
    SAN FRANCISCO: Fitbit, the leading global wearables brand, announced its first smartwatch – Fitbit Ionic™. A health and fitness first platform, Ionic...
    FDA approves first US treatment for Chagas disease

    FDA approves first US treatment for Chagas disease

    savita thakur thakur31 Aug 2017 9:30 AM IST
    The U.S. Food and Drug Administration granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It...
    Sun Pharma Halol unit receives UK clearance: Report

    Sun Pharma Halol unit receives UK clearance: Report

    savita thakur thakur29 Aug 2017 12:44 PM IST
    Sun Pharmaceutical Industries' Halol unit has received clearance from the UK’s pharma regulatory body, reported a leading news daily.The company has...
    PrevNext

    Popular Stories

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok